The best predictive model of direct medical costs showed patients who were hospital - transferring, had initial CD4 cell counts <200 cells / mm3, and received the TDF-containing regimen would have higher direct medical costs than those who accessed for HIV care for the first time, had initial CD4 cell counts from 200 to 499 cells / mm3, and receiving the ZDV-containing regimen.